FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012026579> ?p ?o ?g. }

• W2012026579 endingPage "A356" @default.
• W2012026579 startingPage "A356" @default.
• W2012026579 abstract "Sensitization to pollen is common in the Mediterranean Area, and patients are frequently treated with allergen-specific immunotherapy (SIT); in SIT the precise identification of the disease-eliciting allergen is a requisite for long-lasting therapeutic effect. SIT is prescribed following the EAACI Guidelines using skin prick test (SPT) (Alvarez-Cuesta, 2006). Nowadays, molecular allergology (MA) gives more accurate information about the true patient sensitization, and the usefulness of adding MA to SPT for SIT-indication is demonstrated in (Sastre, 2012). Non-adherence to SIT is a major hurdle, contributing to poor clinical outcomes: 39% of pediatric patients receive SIT for less than 6 months and only 16% for >3 years (Hankin, 2008; similar data for adults in Senna, 2010). In this study, we analyze this multi-dimensional phenomenon merging all the measures available in the literature in one HE model: 1) data on high inaccuracy of guideline-based diagnostics (Sastre); with 2) the hypothesis of improvements by MA; with 3) QoL measures from (Ciprandi, 2010); with 4) SIT-adherence (Hankin and Senna); with 5) SIT monitoring by MA. A total of 141 patients with allergic rhino-conjunctivitis and/or asthma sensitized to pollen from a complex pollen area (Spain) were SPT tested, and subsequently MA was performed using a microarray-based panel of 96 allergens (ImmunoCap ISAC®). The model covers a 3-year timeframe; the outcomes include the number of SITs correctly prescribed, and cost-effectiveness (CE). Uncertainty was addressed with sensitivity analysis. Results show that adding MA to SPT reduces SIT prescriptions by at least 20% (substantial costs saving), and allows for a more targeted (i.e. more successful with a higher QoL) SIT. Our results based on available data from multiple studies show that MA usage for SIT prescription is CE, and can increase SIT-adherence. We recommend a clinical trial capturing all the multi-dimensional aspects of this phenomenon should be conducted for model validation purposes." @default.
• W2012026579 created "2016-06-24" @default.
• W2012026579 creator A5013396026 @default.
• W2012026579 creator A5060163487 @default.
• W2012026579 creator A5089377771 @default.
• W2012026579 date "2012-11-01" @default.
• W2012026579 modified "2023-10-18" @default.
• W2012026579 title "PMD64 Can Molecular Allergology Improve Allergen-Specific Immunotherapy Adherence and Patient Quality of Life in a Complex Pollen Area?" @default.
• W2012026579 doi "https://doi.org/10.1016/j.jval.2012.08.913" @default.
• W2012026579 hasPublicationYear "2012" @default.
• W2012026579 type Work @default.
• W2012026579 sameAs 2012026579 @default.
• W2012026579 citedByCount "4" @default.
• W2012026579 countsByYear W20120265792016 @default.
• W2012026579 countsByYear W20120265792020 @default.
• W2012026579 crossrefType "journal-article" @default.
• W2012026579 hasAuthorship W2012026579A5013396026 @default.
• W2012026579 hasAuthorship W2012026579A5060163487 @default.
• W2012026579 hasAuthorship W2012026579A5089377771 @default.
• W2012026579 hasBestOaLocation W20120265791 @default.
• W2012026579 hasConcept C142724271 @default.
• W2012026579 hasConcept C187212893 @default.
• W2012026579 hasConcept C203014093 @default.
• W2012026579 hasConcept C207480886 @default.
• W2012026579 hasConcept C2776042228 @default.
• W2012026579 hasConcept C2776217527 @default.
• W2012026579 hasConcept C2779787640 @default.
• W2012026579 hasConcept C2780182762 @default.
• W2012026579 hasConcept C2780510475 @default.
• W2012026579 hasConcept C71924100 @default.
• W2012026579 hasConceptScore W2012026579C142724271 @default.
• W2012026579 hasConceptScore W2012026579C187212893 @default.
• W2012026579 hasConceptScore W2012026579C203014093 @default.
• W2012026579 hasConceptScore W2012026579C207480886 @default.
• W2012026579 hasConceptScore W2012026579C2776042228 @default.
• W2012026579 hasConceptScore W2012026579C2776217527 @default.
• W2012026579 hasConceptScore W2012026579C2779787640 @default.
• W2012026579 hasConceptScore W2012026579C2780182762 @default.
• W2012026579 hasConceptScore W2012026579C2780510475 @default.
• W2012026579 hasConceptScore W2012026579C71924100 @default.
• W2012026579 hasIssue "7" @default.
• W2012026579 hasLocation W20120265791 @default.
• W2012026579 hasOpenAccess W2012026579 @default.
• W2012026579 hasPrimaryLocation W20120265791 @default.
• W2012026579 hasRelatedWork W1841668049 @default.
• W2012026579 hasRelatedWork W1982001659 @default.
• W2012026579 hasRelatedWork W1991793603 @default.
• W2012026579 hasRelatedWork W1992480592 @default.
• W2012026579 hasRelatedWork W2049122507 @default.
• W2012026579 hasRelatedWork W2065426285 @default.
• W2012026579 hasRelatedWork W2116176900 @default.
• W2012026579 hasRelatedWork W2135087799 @default.
• W2012026579 hasRelatedWork W2154337427 @default.
• W2012026579 hasRelatedWork W2929289601 @default.
• W2012026579 hasVolume "15" @default.
• W2012026579 isParatext "false" @default.
• W2012026579 isRetracted "false" @default.
• W2012026579 magId "2012026579" @default.
• W2012026579 workType "article" @default.